Cyclophosphamide with or without fluorouracil followed by subcutaneous or intravenous interleukin-2 use in solid tumors: A feasibility off-label experience-Reference-Cited by-同舟云学术

Cyclophosphamide with or without fluorouracil followed by subcutaneous or intravenous interleukin-2 use in solid tumors: A feasibility off-label experience

Published:2019-01 Issue: Volume:113 Page:50-60
ISSN:1043-4666
Container-title:Cytokine
language:en
Short-container-title:Cytokine

Author:

Lo Re Giovanni,Lo Re Francesco,Doretto Paolo,Del Conte Alessandro,Amadio Maria,Cozzi Cinzia,Casarotto Maria Maddalena,Maruzzi Daniele,Marus Wally,Ubiali Paolo,Sandri Paolo

Publisher

Elsevier BV

Subject

Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy

Reference76 articles.

1. The paradigm of mutant p53-expressing cancer stem cells and drug resistance;Shetzer;Carcinogenesis,2014

2. The network of P-glycoprotein and microRNAs interactions;Lopes-Rodrigues;Int. J. Cancer,2014

3. Cancer immunoediting: from immunosurveillance to tumor escape;Dunn;Nat. Immunol.,2002

4. A critical function for type I interferons in cancer immunoediting;Dunn;Nat. Immunol.,2005

5. Tumor-driven evolution of immunosuppressive networks during malignant progression;Kim;Cancer Res.,2006

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growth hormone enhances the CD34+ stem cells repopulation of the male albino rat thymus gland in cyclophosphamide induced injury: immunohistochemical and electron microscopic study;Ultrastructural Pathology;2023-01-29

2. Prediction of anti-CD25 and 5-FU treatments efficacy for pancreatic cancer using a mathematical model;BMC Cancer;2021-11-15

3. Cyclophosphamide, fluorouracil and low-dose interleukin-2 and salvage combination chemotherapy in advanced cutaneous squamous cell carcinoma;Journal of Cancer Metastasis and Treatment;2020-06-24

4. Cyclophosphamide, Fluorouracil and subcutaneous Interleukin-2 in the treatment of advanced GIST: A Case Report;Surgical Case Reports;2019-06-29

5. Cyclophosphamide/fluorouracil/interleukin-2;Reactions Weekly;2019-01